AF
TBIO

Amalgamated Financial’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Amalgamated Financial’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$6K Buy
+64
New +$9.7K ﹤0.01% 2958

Other funds holding TBIO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Amalgamated Financial's TBIO Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Telesis Bio, Inc. Common Stock (TBIO) in Q1 2022: 64 shares worth $6K. The stake represents ﹤0.01% of the portfolio and ranks #2958 among its holdings.

47 funds tracked by Wall St. Rank hold TBIO as of Q1 2022.

  • Amalgamated Financial held 64 shares of Telesis Bio, Inc. Common Stock worth $6K as of Q1 2022.
  • Telesis Bio, Inc. Common Stock was a new Amalgamated Financial position in Q1 2022.
  • Telesis Bio, Inc. Common Stock made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2958 holding.
  • 47 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.